Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach
Juyoung Khwarg, Eunsol Yang, Chan Song Park, Sang Chun Ji, Kyung‐Sang Yu, SeungHwan Lee · 2024
Read Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach by Juyoung Khwarg, Eunsol Yang, Chan Song Park, Sang Chun Ji, Kyung‐Sang Yu, SeungHwan Lee (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11638344.txt.
Description
Juyoung Khwarg and co-authors test how a gene variant changes malaria drug handling in Koreans in this 2024 study. Proguanil enters liver cells through a transporter, OCT1, then an enzyme converts it to its active form. Both steps vary by genetics.
The team reanalyzed a drug interaction study, genotyping 13 volunteers for six variants in the transporter gene. A semi-physiologic model then traced drug and metabolite levels by genotype. The work separates the transporter's effect from the enzyme's, which earlier studies tangled. Dose advice may one day account for both genes. The study shows how archived trial data can answer new genetic questions.
Catalog record
| CREATOR | Juyoung Khwarg, Eunsol Yang, Chan Song Park, Sang Chun Ji, Kyung‐Sang Yu, SeungHwan Lee |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |